Anxiety DisordersDepressive DisordersSubstance Use Disorders (SUD)Safety & Risk ManagementMescaline

The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects

A web-based survey of 452 English-speaking adults found mescaline was typically used infrequently for spiritual or nature-related reasons and produced moderate mystical-type acute effects with minimal challenging effects and few reported legal, psychological or medical harms. About half of respondents had a psychiatric condition and most (>67%) reported improvements after their most memorable mescaline experience, with no differences in effect intensity across mescaline sources, suggesting low abuse potential.

Authors

  • Christopher Timmermann
  • Johannes Ramaekers
  • Alan Davis

Published

Journal of Psychopharmacology
individual Study

Abstract

Background

Mescaline is a naturally occurring psychoactive phenethylamine found in several cacti and historically used ceremonially by Indigenous and Latin American populations. Broader recognition of its possible therapeutic value in Western science began in the 1950s; however, knowledge of the safety profile of mescaline and the extent of its use remains limited. The primary aim of this study is to examine the epidemiology of mescaline use among English-speaking adults.

Methods

About 452 respondents completed a web-based survey designed to assess their previous experience with mescaline (subjective effects, outcome measures, and mescaline type used).

Results

Most respondents reported that they had consumed mescaline infrequently (⩽once/year), for spiritual exploration or to connect with nature (74%). A small number of respondents reported drug craving/desire (9%), whereas very few reported legal (1%), or psychological problems (1%) related to its use, and none reported seeking any medical attention. Overall, respondents rated the acute mystical-type effects as “ moderate,” ego-dissolution and psychological insight effects as “ slight,” and challenging effects as “ very slight.” Most respondents reported that they used Peyote and San Pedro in their most memorable mescaline experience. Overall, the intensity of acute mescaline effects did not differ between mescaline types. About 50% of the sample reported having a psychiatric condition (i.e. depression, anxiety, etc.), and most (>67%) reported improvements in these conditions following their most memorable experience with mescaline.

Conclusion

Findings indicate that the mescaline in any form may produce a psychedelic experience that is associated with the spiritual significance and improvements in the mental health with low potential for abuse.

Available with Blossom Pro

Research Summary of 'The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects'

Introduction

Mescaline (3,4,5-trimethoxyphenethylamine) is a naturally occurring psychedelic phenethylamine found primarily in cacti such as Peyote (Lophophora williamsii) and San Pedro (Trichocereus pachanoi). The introduction summarises pharmacology (primarily 5-HT2A receptor modulation), typical oral dosing (synthetic mescaline ~200–400 mg), duration (peak ~2 h, total 8–12 h), rapid tolerance and low dependence liability, and a long history of ceremonial use among Indigenous peoples. Despite preclinical work and case reports describing visual, emotional and occasionally challenging effects, the authors note a lack of epidemiological data on patterns of use, subjective acute and enduring effects, and harms or benefits of mescaline in broader populations. Vedøy Uthaug and colleagues set out to fill this gap by conducting an international, web-based epidemiological survey of English-speaking adults who had used mescaline at least once. The primary aim was to characterise patterns and motivations for mescaline use, the acute subjective experience and enduring effects, and perceived harms or benefits. Secondary aims included assessing whether medical or psychological functioning changed after use and whether subjective effects or use patterns differed by mescaline type (synthetic, extracted, Peyote, or San Pedro).

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (29)

Papers cited by this study that are also in Blossom

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms

Barrett, F. S., Bradstreet, M. P., Leoutsakos, J. M. S. et al. · Journal of Psychopharmacology (2016)

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)

Lysergic acid diethylamide: side effects and complications

Cohen, S. · Journal of Nervous and Mental Disease (1980)

Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD

Davis, A. K., Streeter Barrett, F., Griffiths, R. R. et al. · Journal of Psychopharmacology (2021)

108 cited
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety

Davis, A. K., So, S., Lancelotta, R. et al. · The American Journal of Drug and Alcohol Abuse (2019)

113 cited
Hallucinogens, Serotonin and Obsessive-Compulsive Disorder

Delgado, P. L., Moreno, F. A. · Journal of Psychoactive Drugs (1998)

61 cited
Cessation and reduction in alcohol consumption and misuse after psychedelic use

Garcia-Romeu, A., Davis, A. K., Fire Erowid et al. · Journal of Psychopharmacology (2019)

211 cited
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

Garcia-Romeu, A., Davis, A. K., Griffiths, R. R. et al. · Frontiers in Psychiatry (2020)

121 cited
Clinical Applications of Hallucinogens: A Review

Garcia-Romeu, A., Kersgaard, B., Addy, P. H. · Experimental and Clinical Psychopharmacology (2016)

174 cited
Show all 29 references
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)

Psychological and cognitive effects of long-term peyote use among Native Americans

Halpern, J. H., Sherwood, A. R., Hudson, J. I. et al. · Biological Psychiatry (2005)

Constructing drug effects: a history of set and setting

Hartogsohn, I. · Drug Science Policy and Law (2017)

389 cited
Psychedelics not linked to mental health problems or suicidal behavior: A population study.

Johansen, P. Ø., Krebs, T. S. · Journal of Psychopharmacology (2015)

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P. et al. · Journal of Psychopharmacology (2014)

Psychedelics and mental health: a population study

Krebs, T. S., Johansen, P. ˚. Ø. · PLOS ONE (2013)

The induction of synaesthesia with chemical agents: a systematic review

Luke, D. P., Terhune, D. B. · Frontiers in Psychology (2013)

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

Maclean, K. A., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2011)

Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being

Mason, N. L., Mischler, E., Uthaug, M. V. et al. · Journal of Psychoactive Drugs (2019)

136 cited
Psychedelics, personality and political perspectives

Nour, M. R., Evans, J., Carhart-Harris, R. L. · Journal of Psychoactive Drugs (2017)

164 cited
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network

Palhano-Fontes, F., Andrade, K. C., Tófoli, L.F. et al. · PLOS ONE (2015)

Psychedelics and the human receptorome

Ray, T. S. · PLOS ONE (2010)

265 cited
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

Rickli, A., Moning, O. D., Hoener, M. C. et al. · European Neuropsychopharmacology (2016)

Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression

Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)

Psychiatry & the psychedelic drugs. Past, present & future

Rucker, J., Iliff, J., Nutt, D. J. · Neuropharmacology (2017)

Ayahuasca’s entwined efficacy: an ethnographic study of ritual healing from ‘addiction’

Talin, P., Sanabria, E. · International Journal of Drug Policy (2017)

93 cited

Cited By (15)

Papers in Blossom that reference this study

Trip killers: Addressing a critical knowledge gap in psychedelic research

O’Mahony, B., Harrington, C., Harkin, A. et al. · Journal of Psychopharmacology (2026)

Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample

Kvam, T-M., Uthaug, M. V., Andersen, K. A. A. et al. · Frontiers in Psychiatry (2023)

17 cited
Transpersonal Ecodelia: Surveying Psychedelically Induced Biophilia

Luke, D., Gandy, S., Irvine, A. et al. · Psychoactives (2023)

17 cited
The association between naturalistic use of psychedelics and co-occurring substance use disorders

Rabinowitz, J., Lev-Ran, S., Gross, R. · Frontiers in Psychiatry (2023)

Altered States of Consciousness During Ceremonial San Pedro Use

Bohn, A., Kiggen, M. H. H., Uthaug, M. V. et al. · International Journal for the Psychology of Religion (2022)

Mescaline: The forgotten psychedelic

Narine, K., Campbell, I., Dyck, J. et al. · Neuropharmacology (2022)

98 cited
Naturalistic Psychedelic Use: A World Apart from Clinical Care

Glynos, N., Fields, C. W., Barron, J. et al. · Journal of Psychoactive Drugs (2022)

Show all 15 papers

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

The epidemiology of mescaline use: Pattern of... — Research Summary & Context | Blossom